Moutih Rafei

Department of Microbiology, Université de Montréal

Research Area

Biography

Moutih Rafei has not added Biography.
If you are Moutih Rafei and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2	Year
Publication title Cited by 10	2017
Publication title Cited by 3	2022

Other Publications

Article	Year
A GMCSF and IL-15 fusokine leads to paradoxical immunosuppression in vivo via asymmetrical JAK/STAT signaling through the IL-15 receptor complex. Blood\| PubMed ID: 17082320	2007
Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction. Blood\| PubMed ID: 18812467	2008
Mesenchymal stromal cells engineered to express erythropoietin induce anti-erythropoietin antibodies and anemia in allorecipients. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 19088705	2009
Selective inhibition of CCR2 expressing lymphomyeloid cells in experimental autoimmune encephalomyelitis by a GM-CSF-MCP1 fusokine. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 19234156	2009
Autologous bone marrow stromal cells genetically engineered to secrete an igf-I receptor decoy prevent the growth of liver metastases. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 19367255	2009
Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 19414750	2009
Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretome. Blood\| PubMed ID: 19587377	2009
An engineered GM-CSF-CCL2 fusokine is a potent inhibitor of CCR2-driven inflammation as demonstrated in a murine model of inflammatory arthritis. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 19592643	2009
Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 19602999	2009
A granulocyte-macrophage colony-stimulating factor and interleukin-15 fusokine induces a regulatory B cell population with immune suppressive properties. Nature medicine\| PubMed ID: 19668193	2009
[A chimeric cytokine to help autoimmune diseases]. Medecine sciences : M/S\| PubMed ID: 20188040	2010
A fusion of GMCSF and IL-21 initiates hypersignaling through the IL-21Ralpha chain with immune activating and tumoricidal effects in vivo. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 20389285	2010
GIFT15 fusokine to foil immunity's follies. Immunotherapy\| PubMed ID: 20635907	2009
A dendritic cell population generated by a fusion of GM-CSF and IL-21 induces tumor-antigen-specific immunity. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 21076067	2010
A CCL2-based fusokine as a novel biopharmaceutical for the treatment of CCR2-driven autoimmune diseases. Critical reviews in immunology\| PubMed ID: 21083526	2010
Development and function of innate polyclonal TCRalphabeta+ CD8+ thymocytes. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 21844388	2011
A MCP1 fusokine with CCR2-specific tumoricidal activity. Molecular cancer\| PubMed ID: 21943176	2011
Inducible IL10(+) suppressor B cells inhibit CNS inflammation and T helper 17 polarization. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 22760541	2012
Differential effects of γc cytokines on postselection differentiation of CD8 thymocytes. Blood\| PubMed ID: 23043071	2013
Interleukin-21 accelerates thymic recovery from glucocorticoïd-induced atrophy. PloS one\| PubMed ID: 24023776	2013
Ex vivo generation of murine IL-10-producing B cells by fusokines. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 25015277	2014
Inflammatory monocytes promote progression of Duchenne muscular dystrophy and can be therapeutically targeted via CCR2. EMBO molecular medicine\| PubMed ID: 25312642	2014
Inducible IL10(+) Suppressor B Cells Inhibit CNS Inflammation and T Helper 17 Polarization. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 28157533	2012
A Fusion of GMCSF and IL-21 Initiates Hypersignaling Through the IL-21Rα Chain With Immune Activating and Tumoricidal Effects In Vivo. Molecular therapy : the journal of the American Society of Gene Therapy\| PubMed ID: 28178447	2010
Interleukin-21 promotes thymopoiesis recovery following hematopoietic stem cell transplantation. Journal of hematology & oncology\| PubMed ID: 28615039	2017
Restoring thymic function: Then and now. Cytokine\| PubMed ID: 31108430	2019
Heart failure drug proscillaridin A targets MYC overexpressing leukemia through global loss of lysine acetylation. Journal of experimental & clinical cancer research : CR\| PubMed ID: 31196146	2019
Cardiotrophin-Like Cytokine Factor 1 Exhibits a Myeloid-Biased Hematopoietic-Stimulating Function. Frontiers in immunology\| PubMed ID: 31552057	2019
Mesenchymal Stem Cells Beyond Regenerative Medicine. Frontiers in cell and developmental biology\| PubMed ID: 32133358	2020
A Novel Sulfonyl-Based Small Molecule Exhibiting Anti-cancer Properties. Frontiers in pharmacology\| PubMed ID: 32231565	2020
TACIMA-218: A Novel Pro-Oxidant Agent Exhibiting Selective Antitumoral Activity. Molecular cancer therapeutics\| PubMed ID: 33087510	2021
Integrative Transcriptome Analyses Empower the Anti-COVID-19 Drug Arsenal. iScience\| PubMed ID: 33103068	2020
FcεR1-expressing nociceptors trigger allergic airway inflammation. The Journal of allergy and clinical immunology\| PubMed ID: 33453289	2021
Thymoproteasome-Expressing Mesenchymal Stromal Cells Confer Protective Anti-Tumor Immunity Cross-Priming of Endogenous Dendritic Cells. Frontiers in immunology\| PubMed ID: 33542714	2020
Autologous BMAC Therapy Improves Spinal Degenerative Joint Disease in Lower Back Pain Patients. Frontiers in medicine\| PubMed ID: 33816523	2021
Cell Therapy: Types, Regulation, and Clinical Benefits. Frontiers in medicine\| PubMed ID: 34881261	2021
Bone marrow aspirate concentrate versus platelet-rich plasma for treating knee osteoarthritis: a one-year non-randomized retrospective comparative study. BMC musculoskeletal disorders\| PubMed ID: 34980045	2022
UM171A-induced ROS promote antigen cross-presentation of immunogenic peptides by bone marrow-derived mesenchymal stromal cells. Stem cell research & therapy\| PubMed ID: 35012668	2022
Engineering immunoproteasome-expressing mesenchymal stromal cells: A potent cellular vaccine for lymphoma and melanoma in mice. Cell reports. Medicine\| PubMed ID: 35028603	2021
Humoral Immunity to Allogeneic Immunoproteasome-Expressing Mesenchymal Stromal Cells Requires Efferocytosis by Endogenous Phagocytes. Cells\| PubMed ID: 35203247	2022
Promoting antigen escape from dendritic cell endosomes potentiates anti-tumoral immunity. Cell reports. Medicine\| PubMed ID: 35492876	2022
LSD1 Inhibition Enhances the Immunogenicity of Mesenchymal Stromal Cells by Eliciting a dsRNA Stress Response. Cells\| PubMed ID: 35681511	2022
Accum™ Technology: A Novel Conjugable Primer for Onco-Immunotherapy. Molecules (Basel, Switzerland)\| PubMed ID: 35744930	2022